Sheltagen Medical

Company Overview

Snapshot

Founded in December 2009 by Nahum Rosenberg, Sheltagen Medical operates with 1-10 employees. The company is currently in the R&D product stage, focusing on developing human bone tissue for implantation.

Business overview

Sheltagen Medical is a Health Tech & Life Sciences company specializing in the development of autologous bone grafts for orthopedic and dental surgery. The company's core technology involves producing patient-specific human bone tissue using the patient's own bone cells and blood components. This methodology aims to prevent transplant rejection by culturing bone cells on an inorganic matrix in self-blood serum, exposed to mechanical stimulation. Sheltagen Medical primarily serves the healthcare industry, targeting providers in the medical devices, medical treatment, and biomaterials & tissue engineering sectors.

Company Intelligence Q&A

What is Sheltagen Medical's primary focus?

Sheltagen Medical focuses on developing human bone tissue for implantation in patients requiring bone grafts for fractures or spinal instability, utilizing autologous cells to prevent rejection.

When was Sheltagen Medical founded?

Sheltagen Medical was founded in December 2009.

Who is the founder of Sheltagen Medical?

Nahum Rosenberg is the founder and CEO of Sheltagen Medical.

What markets does Sheltagen Medical serve?

Sheltagen Medical serves the healthcare market, specifically targeting providers in the medical devices, medical treatment, and biomaterials & tissue engineering sectors.

What is the product stage of Sheltagen Medical?

Sheltagen Medical is currently in the R&D product stage, developing human bone tissue for implantation. The company has not yet launched a commercial product as of June 2026.